-
Better Coronavirus Stock: Regeneron or Gilead Sciences?
Post on 6/18/20
-
IVERIC bio Proposes Offering of Common Stock
Post on 6/17/20
-
Provention Bio Announces Proposed Public Offering of Common Stock
Post on 6/17/20
-
Actinium Pharmaceuticals Announces Proposed Public Offering
Post on 6/17/20
-
Actinium Pharmaceuticals Announces Pricing of $25.0 Million Public Offering
Post on 6/17/20
-
Phosphorus Announces Partnership With BioIQ
Post on 6/17/20
-
TapestryHealth Purchases Telehealth Software Leader
Post on 6/17/20
-
Merck Prices $4.5 Billion Debt Offering
Post on 6/17/20
-
Cohen Children’s Medical Center Ranked One of Nation’s Best by US News
Post on 6/16/20
-
Bristol Myers Squibb Announces Commencement of Registered Exchange Offers
Post on 6/16/20
-
Fusion Pharmaceuticals IPO: Say No To One-Product Biotech IPOs
Post on 6/16/20
-
Longhorn Vaccines and Diagnostics and Greenfield Global Partner
Post on 6/15/20
-
Cigna Foundation Announces Availability Of $5 Million In Grants
Post on 6/15/20
-
bluebird bio Reports Dramatic Improvement in Sickle Cell Patients with LentiGlobin Gene Therapy
Post on 6/15/20
-
Is Merck A Great Dividend Stock?
Post on 6/15/20
-
Dr. Reddy's Laboratories Enters into a Licensing Agreement with Gilead Sciences for Remdesivir
Post on 6/14/20
-
Royalty Pharma Announce $255 Million Purchase Agreement
Post on 6/12/20
-
Better Buy: bluebird bio vs. Gilead Sciences
Post on 6/12/20
-
Regeneron Begins Human Trials of a Potential COVID-19 Treatment
Post on 6/12/20
-
The #1 Pick In Health Care: Johnson & Johnson
Post on 6/11/20
-
Fosun Launches Partnership With Sing For Hope To Benefit Health Care Workers At Local Hospitals
Post on 6/11/20
-
Reata Pharmaceuticals and Blackstone Life Sciences Announce $350 Million Investment
Post on 6/11/20
-
Here's Why The Clouds Have Lifted For Quest Diagnostics
Post on 6/11/20
-
Johnson & Johnson to Begin Coronavirus Vaccine Clinical Trial in July
Post on 6/11/20
-
DelMar to Acquire Adgero Biopharmaceuticals
Post on 6/10/20
New York
